// App-Quantinova.ai

824P : ARV7 status and CTC count: A combined biomarker for the baseline therapeutic decision in each line of mCRPC treatment

Researchers

Presenter

  • E.Bournakis

Principal Investigators

  • E.Lianidou

  • A.Strati

  • M.Zavridou

  • A.Sfika

  • A.Bournakis

  • C.Papadimitriou

Medical Centers

  • Oncology Department, ARETEION University Hospital of Athens, Athens, Greece

  • Chemistry, Laboratory of Analytical Chemistry, University of Athens, Athens, Greece

Locations

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • Androgen receptor variant 7

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved